Correction by unknown
CORRECTIONS  The Journal of Experimental Medicine 
In the article "Functional properties of a  unique subset of cytotoxic CD3 + T  lymphocytes 
that  express  Fc receptors  for IgG (CDI6/Leu-11  antigen)"  by Lewis L.  Lanier,  Thomas 
J. Kipps,  and Joseph H.  Phillips (December  1985,  162:2089),  figures 7-10  were printed 
without proper explanatory notes. The figures, with their corrected legends, are reprinted 
here. 
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FIGURE 7.  NK cell activity of CD3+,CD16 + and  CD3-,CDI6 ÷ lymphocytes.  Nonadherent 
PBL (D.  H.), depleted of B cells using a  nylon wool column, were stained with FITC-anti- 
Leu-I la and  PE-anti-Leu-4. The CD3+,CD16 + and CD3-,CDI6 + cells were separated using 
the FACS. Reanalysis of the separated subpopulations indicated >95% purity. Morphological 
examination revealed that >99% of the sorted cells were lymphocytes. The sorted subpopu- 
lations  and  stained,  unsorted  lymphocytes  were  tested  for  cytotoxic activity against  5~Cr- 
labelled K562 tumor cells in a 4-h radioisotope-release assay  (A). Stained unsorted cells (O); 
CD3-,Leu-11 + cells (11); CD3+,Leu-11 ÷ cells (0).  The  CD3+,CD16 + and  CD3-,CD16 + cells 
were placed in culture medium containing purified I L-2, and again tested for cytotoxic activity 
against K562 and CCRF-SB tumor cells after  1 wk. (B). Analysis of the antigenic phenotypes 
after 1 wk in culture indicated that the CD3-,CD16 + and CD3÷,CD16  ÷ populations contained 
~98% CD3-,CDt6  + and CD3+,CDI6  ÷ cells, respectively. 2% of the cells in the CD3÷,CD16  + 
culture  were CD3-,CD16 + cells.  By extrapolation  of the effector/target (E/T) curves,  this 
small contamination  of activated CD3-,CD16 + NK cells may account  for the low levels of 
cytotoxicity observed against  K562  in  the CD3*,CDI6  + population.  With  K562  as target: 
CD3-,Leu-11 ÷  (It);  CD3+,Leu-11 ÷  (O).  With  SB  as  target:  CD3-,Leu-11 ÷  ([-1); 
CD3+,Leu-1 1  + (0)- 
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FIGURE 8.  ADCC  activity  of CD5-  and  CD5 + lymphocytes and  inhibition  by anti-Leu-11 
antibody.  Nonadherent  peripheral  blood  mononuclear  cells  from  D.  H.  were  stained  with 
FITC-anti-Leu-1  (CDS) and separated into CD5 + and CD5- subsets using a  FACS. Reanalysis 
indicated  98% purity.  A: CDS-  (right)  and  CD5 + (left) lymphocytes  were  tested  for  ADCC 
activity against ~lCr-labelled JY tumor cells preincubated with an lgG2a anti-HLA mAb,  ME1 
(ME13,~,,  /--I). No cytoto?dcity  was observed  against JY cells not preincubated  with antibody 
(0). B: Anti-Leu-11 or anti-Leu-15 mAb were added to the ADCC assay (using ME13,e,-coated 
JY as target) at 5/~g/m], JY target cells do not express the CD16  (Leu-11) or CRy (Leu-15) 
antigens. 
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FIGURE 9.  ADCC activity of CD3÷,CD16 ÷ lymphocytes. After 3 wk culture in lL-2-contain- 
ing medium,  CD3-,CDI 6 + and CD3+,CD16 + lymphocytes were tested for NK cell-mediated 
cytotoxicity against  the JY  B  lymphoblastoid  cell  line  in  a  4-h  radioisotope-release  assay. 
CD3-,Leu-11 + (O); CD3+,Leu -11 + (FI) (A). In B, the ADCC activity of the CD3+,CDI 6 + cells 
was tested  in a  4-h  radioisotope-release assay using 51Cr-labelled JY cells preincubated  with 
isotype switch-variants of the MA2.1  (anti-HLA-A2-specific) mAb. Effectors were CD3+,Leu - 
11 +. IgG2a MA2.1  (O), IgG2b MA2.1  (O), lgG1  MA2.1  (11), none (f-I). 
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FIGURE  10.  Anti-CD3-induced cytotoxicity mediated by CD3+,CD16 + lymphocytes. After 3 
wk in culture in IL-2-containing medium, CD3÷,CD16 ÷ lymphocytes were tested for cytotoxic 
activity against theJY (top),  Daudi (middle), and LCL 207 (bottom) B cell lines in the presence 
of anti-Leu-4  mAb (4 ug/m[) (11), anti-Leu-11  mAb (4 #g/ml; Daudi experiment) (El), or no 
mAb (D). 
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